REGENXBIO
$32.389876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$32.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.37 (-4.06%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell REGENXBIO and other stocks, options, ETFs, and crypto commission-free!
About RGNX
REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Read More The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Employees
257
Headquarters
Rockville, Maryland
Founded
2008
Market Cap
1.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
775.50K
High Today
$33.92
Low Today
$31.33
Open Price
$33.31
Volume
367.45K
52 Week High
$59.98
52 Week Low
$20.03
Collections
RGNX Earnings
-$0.94
-$0.59
-$0.24
$0.11
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours